Alpha Spread
Search stocks here...
Sign Up Log in
Dashboard Stock Screener Stock Comparison Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator
Pricing Market News Investing Ideas
Alpha Spread
Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Alpha Spread
Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
PepGen Inc Logo

PepGen Inc
NASDAQ:PEPG

Watchlist Manager
PepGen Inc Logo
PepGen Inc
NASDAQ:PEPG
Watchlist
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Dividends
Investor Relations
Discount Rate
Price: 1.87 USD -3.61% Market Closed
Market Cap: 61.3m USD
Have any thoughts about
PepGen Inc?
Write Note
Write Note Create Alert Ask AI
Add Note Why Create Notes?
Capture your thoughts
Note Buy Sell Hold Pass
US
Johnson & Johnson
NYSE:JNJ
Pharmaceuticals
US
Berkshire Hathaway Inc
NYSE:BRK.A
Financial Services
US
Bank of America Corp
NYSE:BAC
Banking
US
Mastercard Inc
NYSE:MA
Technology
US
UnitedHealth Group Inc
NYSE:UNH
Health Care
US
Exxon Mobil Corp
NYSE:XOM
Energy
US
Pfizer Inc
NYSE:PFE
Pharmaceuticals
US
Palantir Technologies Inc
NYSE:PLTR
Technology
US
Nike Inc
NYSE:NKE
Textiles, Apparel & Luxury Goods
US
Visa Inc
NYSE:V
Technology
CN
Alibaba Group Holding Ltd
NYSE:BABA
Retail
US
JPMorgan Chase & Co
NYSE:JPM
Banking
US
Coca-Cola Co
NYSE:KO
Beverages
US
Walmart Inc
NYSE:WMT
Retail
US
Verizon Communications Inc
NYSE:VZ
Telecommunication
US
Chevron Corp
NYSE:CVX
Energy


Add Price Alert
Price Target:
Last Price: 1.87 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch
Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?
Close
Back
Delete Note

Do you really want to delete this note?
This action cannot be undone.

Delete
Cancel
PEPG Alert
PepGen Inc
1.87
-0.07 (-3.61%)
52 Week Range
1
9.76
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

Johnson & Johnson
NYSE:JNJ
US
Berkshire Hathaway Inc
NYSE:BRK.A
US
Bank of America Corp
NYSE:BAC
US
Mastercard Inc
NYSE:MA
US
UnitedHealth Group Inc
NYSE:UNH
US
Exxon Mobil Corp
NYSE:XOM
US
Pfizer Inc
NYSE:PFE
US
Palantir Technologies Inc
NYSE:PLTR
US
Nike Inc
NYSE:NKE
US
Visa Inc
NYSE:V
US
Alibaba Group Holding Ltd
NYSE:BABA
CN
JPMorgan Chase & Co
NYSE:JPM
US
Coca-Cola Co
NYSE:KO
US
Walmart Inc
NYSE:WMT
US
Verizon Communications Inc
NYSE:VZ
US
Chevron Corp
NYSE:CVX
US
Delete Alert

This alert will be permanently deleted.

Delete
Cancel
Ask me anything about
PepGen Inc

What unique competitive advantages
does PepGen Inc hold over its rivals?

What risks and challenges
does PepGen Inc face in the near future?

Provide an overview of the primary business activities
of PepGen Inc.

Show me price targets
for PepGen Inc made by professional analysts.

Provide an overview of the primary business activities
of PepGen Inc.

What unique competitive advantages
does PepGen Inc hold over its rivals?

What risks and challenges
does PepGen Inc face in the near future?

Has there been any significant insider trading activity
in PepGen Inc recently?

Summarize the latest earnings call
of PepGen Inc.

Show all valuation multiples
for PepGen Inc.

Provide P/S
for PepGen Inc.

Provide P/E
for PepGen Inc.

Provide P/OCF
for PepGen Inc.

Provide P/FCFE
for PepGen Inc.

Provide P/B
for PepGen Inc.

Provide EV/S
for PepGen Inc.

Provide EV/GP
for PepGen Inc.

Provide EV/EBITDA
for PepGen Inc.

Provide EV/EBIT
for PepGen Inc.

Provide EV/OCF
for PepGen Inc.

Provide EV/FCFF
for PepGen Inc.

Provide EV/IC
for PepGen Inc.

Show me price targets
for PepGen Inc made by professional analysts.

What are the Revenue projections
for PepGen Inc?

How accurate were the past Revenue estimates
for PepGen Inc?

What are the Net Income projections
for PepGen Inc?

How accurate were the past Net Income estimates
for PepGen Inc?

What are the EPS projections
for PepGen Inc?

How accurate were the past EPS estimates
for PepGen Inc?

What are the EBIT projections
for PepGen Inc?

How accurate were the past EBIT estimates
for PepGen Inc?

Compare the revenue forecasts
for PepGen Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of PepGen Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of PepGen Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of PepGen Inc compared to its peers.

Compare the P/E ratios
of PepGen Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing PepGen Inc with its peers.

Analyze the financial leverage
of PepGen Inc compared to its main competitors.

Show all profitability ratios
for PepGen Inc.

Provide ROE
for PepGen Inc.

Provide ROA
for PepGen Inc.

Provide ROIC
for PepGen Inc.

Provide ROCE
for PepGen Inc.

Provide Gross Margin
for PepGen Inc.

Provide Operating Margin
for PepGen Inc.

Provide Net Margin
for PepGen Inc.

Provide FCF Margin
for PepGen Inc.

Show all solvency ratios
for PepGen Inc.

Provide D/E Ratio
for PepGen Inc.

Provide D/A Ratio
for PepGen Inc.

Provide Interest Coverage Ratio
for PepGen Inc.

Provide Altman Z-Score Ratio
for PepGen Inc.

Provide Quick Ratio
for PepGen Inc.

Provide Current Ratio
for PepGen Inc.

Provide Cash Ratio
for PepGen Inc.

What is the historical Revenue growth
over the last 5 years for PepGen Inc?

What is the historical Net Income growth
over the last 5 years for PepGen Inc?

What is the current Free Cash Flow
of PepGen Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for PepGen Inc.

Popular Prompts Strategic Analysis Valuation Future Outlook Peer Analysis Profitability Solvency Financials
Relative ValueValuation MultiplesMultiples Across CompetitorsSee Also
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

There is not enough data to reliably calculate the relative value of PEPG.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Valuation FAQ:
What is Relative Valuation?
How is Relative Value calculated?
PEPG Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

N/A
P/S
P/S
Price to Sales
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.6
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-3.3
Median 5Y
-3.4
Industry
24.3
Forward
-0.6
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-3.5
Median 5Y
-3.8
Industry
20.8
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-3.5
Median 5Y
-3.7
Industry
22.3
More Details
0.9
P/B
P/B
Price to Book Value
0.9
vs History
78
vs Industry
72
Median 3Y
1.4
Median 5Y
1.3
Industry
3.1
More Details
N/A
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.3
More Details
0.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
0.1
vs History
19
vs Industry
21
Median 3Y
-0.6
Median 5Y
-0.5
Industry
5.4
Forward
0.1
More Details
0.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
0.1
vs History
19
vs Industry
19
Median 3Y
-0.6
Median 5Y
-0.5
Industry
5.7
Forward
0.1
More Details
0.1
EV/OCF
EV/OCF
Enterprise Value to OCF
0.1
vs History
19
vs Industry
23
Median 3Y
-0.8
Median 5Y
-0.6
Industry
6.8
More Details
0.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
0.1
vs History
19
vs Industry
18
Median 3Y
-0.7
Median 5Y
-0.6
Industry
5.1
More Details
Negative
EV/IC
EV/IC
Enterprise Value to IC
N/A
vs History
vs Industry
19
Median 3Y
2.3
Median 5Y
2.1
Industry
5.3
More Details

Multiples Across Competitors

PEPG Competitors Multiples
PepGen Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries United States of America United Kingdom Canada New Zealand Germany Bermuda Ireland Luxembourg Austria Italy France Belgium Netherlands Portugal Switzerland Spain Lithuania Estonia Latvia Finland Iceland Sweden Norway Denmark Israel Hong Kong Korea Poland Hungary Philippines Singapore India Japan Pakistan Australia Chile Saudi Arabia Thailand China Indonesia Greece South Africa Vietnam Malaysia Brazil Argentina Mexico Croatia Turkey Taiwan Peru Russia Cyprus Cayman Islands Papua New Guinea Mongolia Guernsey British Virgin Islands Panama Puerto Rico Monaco Colombia Uruguay United Arab Emirates Macao Egypt Bahamas Jersey Anguilla Nicaragua Isle of Man Mauritius Guam Venezuela Czech Republic Malta Liechtenstein Georgia Cambodia Azerbaijan Ukraine French Guiana Martinique Costa Rica Gibraltar Morocco Virgin Islands (U.S.) Faroe Islands Nigeria Bulgaria Slovenia Slovakia Romania Kazakhstan Jordan Kenya Zimbabwe Malawi
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
PepGen Inc
NASDAQ:PEPG
61.3m USD 0 -0.6 0.1 0.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 563 902.2 -159 524.2 -193 713.3 -191 502.8
US
Abbvie Inc
NYSE:ABBV
390.5B USD 6.7 104.9 17.1 24.8
US
Amgen Inc
NASDAQ:AMGN
148.1B USD 4.2 22.4 17.7 17.7
US
Gilead Sciences Inc
NASDAQ:GILD
140.9B USD 4.9 22.3 10.4 14.3
US
E
Epizyme Inc
F:EPE
94.1B EUR 2 099 -535.6 -583.2 -567.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
99B USD 8.7 27.2 20 20.9
AU
CSL Ltd
ASX:CSL
96B AUD 4.1 21.3 14.2 17.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
63.4B USD 4.5 14.2 12.8 14.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
58.9B USD 23.9 -184.5 -461.2 -316.6
US
S
Seagen Inc
F:SGT
39.3B EUR 20.2 -62 -66.9 -60.3
P/S Multiple
Revenue Growth P/S to Growth
US
PepGen Inc
NASDAQ:PEPG
Average P/S: 3 356 607.8
Not Available 		N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 563 902.2
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.7
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.2
4%
1.1
US
Gilead Sciences Inc
NASDAQ:GILD
4.9
4%
1.2
US
E
Epizyme Inc
F:EPE
2 099
N/A N/A
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
8.7
10%
0.9
AU
CSL Ltd
ASX:CSL
4.1
6%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.5
5%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
23.9
41%
0.6
US
S
Seagen Inc
F:SGT
20.2
30%
0.7
P/E Multiple
Earnings Growth PEG
US
PepGen Inc
NASDAQ:PEPG
Average P/E: 35.4
Negative Multiple: -0.6 		N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -159 524.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
104.9
88%
1.2
US
Amgen Inc
NASDAQ:AMGN
22.4
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
22.3
191%
0.1
US
E
Epizyme Inc
F:EPE
Negative Multiple: -535.6 N/A N/A
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.2
N/A N/A
AU
CSL Ltd
ASX:CSL
21.3
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.2
6%
2.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -184.5 N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -62 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
PepGen Inc
NASDAQ:PEPG
Average EV/EBITDA: 13.2
0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 713.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
17.1
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.7
10%
1.8
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
6%
1.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -583.2 N/A N/A
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
20
17%
1.2
AU
CSL Ltd
ASX:CSL
14.2
10%
1.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.8
9%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -461.2 N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.9 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
PepGen Inc
NASDAQ:PEPG
Average EV/EBIT: 15.7
0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -191 502.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
24.8
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.7
19%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
14.3
12%
1.2
US
E
Epizyme Inc
F:EPE
Negative Multiple: -567.7 N/A N/A
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
20.9
17%
1.2
AU
CSL Ltd
ASX:CSL
17.7
14%
1.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.5
12%
1.2
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -316.6 N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.3 N/A N/A

See Also

Summary
PEPG intrinsic value, competitors valuation, and company profile.
DCF Valuation
PEPG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PEPG stock valuation using valuation multiples.
Wall Street Estimates
PEPG price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PEPG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 283,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

What is relative valuation?

Relative valuation is used to value companies by comparing them to other businesses based on certain metrics such as EV/Revenue, EV/EBITDA, and P/E ratios.

Relative valuation is one of two methods of placing a monetary value on a company; the other is Discounted Cash Flow valuation method. We use a combination of these two methods to calculate the Intrinsic Value of stock as accurately as possible.

Read more
Close
How is Relative Value calculated?

Our algorithm takes into account all the information about the company's valuation multiples (their historical values, how competitors are priced, and much more) and consolidates it into one single number - relative value.

Read more
Close
Alpha Spread
Become a more intelligent investor
Sign up with Google
OR
Sign up with email
Already have an account? Sign in
By using Alpha Spread you are agreeing to our
Terms of Service and Privacy Policy.
Sign In
Become a more intelligent investor
Sign in with Google
OR
Sign in with email
Not a member? Sign Up
By using Alpha Spread you are agreeing to our
Terms of Service and Privacy Policy.
Recently Viewed Most Popular Most Undervalued Wide Economic Moat High Profitability High Solvency
PepGen Inc
NASDAQ:PEPG
1.87 USD
-3.61%

Companies most frequently analyzed and tracked by Alpha Spread users.

Johnson & Johnson
NYSE:JNJ
173.96 USD
-1.83%
Berkshire Hathaway Inc
NYSE:BRK.A
735 440.02 USD
-0.53%
Bank of America Corp
NYSE:BAC
52.08 USD
1.32%
Mastercard Inc
NYSE:MA
585.96 USD
-2.12%
UnitedHealth Group Inc
NYSE:UNH
335.12 USD
-1.9%
Exxon Mobil Corp
NYSE:XOM
114.35 USD
-0.82%
View Most Popular Stocks Full List

Every business has a fair value, its true price. Where market price tells you the price other people are willing to pay, fair value shows the value of a stock based on an analysis of the company’s actual financials (such as cash balance, revenue, operating margin, etc).

Franklin Covey Co
NYSE:FC
19.29 USD
-0.92%
Mohawk Industries Inc
NYSE:MHK
133.54 USD
1.72%
Ardmore Shipping Corp
NYSE:ASC
13.22 USD
-0.53%
ASGN Inc
NYSE:ASGN
49.51 USD
-2.62%
Skyworks Solutions Inc
NASDAQ:SWKS
76.95 USD
3.3%
Weatherford International PLC
NASDAQ:WFRD
65.36 USD
2.48%
View Most Undervalued Stocks Full List

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term.

Johnson & Johnson
NYSE:JNJ
173.96 USD
-1.83%
Bank of America Corp
NYSE:BAC
52.08 USD
1.32%
Mastercard Inc
NYSE:MA
585.96 USD
-2.12%
Salesforce Inc
NYSE:CRM
244.1 USD
0.78%
Abbvie Inc
NYSE:ABBV
221.09 USD
0.13%
Home Depot Inc
NYSE:HD
418.25 USD
0.3%
View Wide Economic Moat Stocks Full List

Companies demonstrating exceptional profitability and efficient operations.

Monolithic Power Systems Inc
NASDAQ:MPWR
920.56 USD
4.89%
Applovin Corp
NASDAQ:APP
617.64 USD
1.81%
NVIDIA Corp
NASDAQ:NVDA
176.24 USD
3.49%
Cal-Maine Foods Inc
NASDAQ:CALM
104.92 USD
1.35%
Pro Medicus Ltd
ASX:PME
298.81 AUD
1.33%
P
Plover Bay Technologies Ltd
HKEX:1523
6.7 HKD
-0.59%
View High Profitability Stocks Full List

Companies with the lowest probability of bankruptcy.

Salesforce Inc
NYSE:CRM
244.1 USD
0.78%
Accenture PLC
NYSE:ACN
239.91 USD
-0.55%
ServiceNow Inc
NYSE:NOW
945.38 USD
-0.53%
Spotify Technology SA
NYSE:SPOT
734.47 USD
3.86%
Applied Materials Inc
NASDAQ:AMAT
190.09 USD
6.71%
NVIDIA Corp
NASDAQ:NVDA
176.24 USD
3.49%
View High Solvency Stocks Full List
Stock Screener
Discover stocks tailored to your investment strategy.
Open Stock Screener
You don't have any saved screeners yet
Other Tools
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF
Discount Rate Calculator
Cost of Equity & WACC

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett
Create Your Free Account
Already have an account? Sign in
Gain access to the world’s leading value investing platform
Gain access to the world’s leading value investing platform

By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.

Sign up with Google
OR
Create Free Account

By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.